ATA leads coalition to address marijuana rescheduling safety concerns
Key takeaways
- ATA urged federal agencies to preserve marijuana testing for safety-sensitive transportation workers.
- The coalition warned rescheduling could disrupt DOT drug testing and employer compliance.
- Transportation groups called for coordinated federal guidance before marijuana rescheduling proceeds.
The American Trucking Associations (ATA) recently led a coalition of 19 transportation and safety organizations in sending a letter to federal agencies raising concerns about the proposed rescheduling of marijuana under the Controlled Substances Act.
ATA joined organizations from the trucking, aviation, rail, pipeline, and other transportation sectors in urging the U.S. Department of Justice, U.S. Drug Enforcement Administration, U.S. Department of Health and Human Services, and U.S. Department of Transportation to coordinate efforts to protect the current drug testing framework for safety-sensitive transportation employees.
The coalition said moving marijuana from Schedule I to Schedule III could create legal and regulatory uncertainty if existing laboratory certification procedures and testing standards are not maintained. While the Department of Transportation has indicated it intends to continue marijuana testing, the coalition said questions remain about whether the agency will retain access to the scientific and procedural infrastructure currently supported through HHS.
The letter also noted that marijuana remains one of the most frequently detected drugs in transportation testing programs and warned that disruptions to current testing procedures could affect employers' ability to maintain compliance with federal safety requirements.
Coalition recommendations
The coalition called on federal agencies to:
- Preserve marijuana testing for safety-sensitive transportation workers over the long term.
- Affirm the authority of DOT-regulated employers to continue marijuana testing.
- Maintain HHS laboratory certification and testing guidelines that support DOT programs.
- Develop a coordinated federal strategy to address transportation safety issues related to marijuana rescheduling.
What this means for the trucking industry
If marijuana is rescheduled without preserving the existing testing framework, fleets and other DOT-regulated employers could face uncertainty about how to comply with federal drug testing requirements. The coalition's request highlights the importance of maintaining clear regulatory guidance so carriers can continue enforcing safety programs while avoiding compliance gaps that could affect drivers, employers, and the broader transportation system.
